INFORMAZIONI SU QUESTO ARTICOLO

Cita

Nikfarjam J, Chambers E. Congenital melanocytic nevi and the risk of malignant melanoma: establishing a guideline for primary-care physicians. Einstein J Biol Med. 2011;27(2):59-66. doi: 10.23861/EJBM20112745. Nikfarjam J Chambers E Congenital melanocytic nevi and the risk of malignant melanoma: establishing a guideline for primary-care physicians Einstein J Biol Med 2011 27 2 59 66 10.23861/EJBM20112745Open DOISearch in Google Scholar

Shah J, Feintisch AM, Granick MS. Congenital melanocytic nevi. Eplasty. 2016 Jan 28;16:ic4. Shah J Feintisch AM Granick MS Congenital melanocytic nevi Eplasty 2016 28 1610.1097/MOP.000000000000038427307047Search in Google Scholar

del Carmen Boente M. Congenital melanocytic nevi. p. 249-60. In: Pediatric skin of color. Eds. Silverberg NB, Durán-McKinster C, Tay Y-K. New York: Springer-Verlag, 2015; XV, 473 p. ISBN 9781-4614-6653-6 (hardcover). ISBN 978-1-4614-6654-3 (eBook). doi: 10.1007/978-1-4614-6654-3. Carmen Boente M del Congenital melanocytic nevi. p. 249-60 Pediatric skin of color. Eds. Silverberg NB, Durán-McKinster C, Tay Y-K New York Springer-Verlag 2015 XV, 473 p. ISBN 9781-4614-6653-6 (hardcover). ISBN 978-1-4614-6654-3 (eBook) 10.1007/978-1-4614-6654-3Open DOISearch in Google Scholar

Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr. 2016;28(4):476-82. doi: 10.1097/MOP.0000000000000384. Price HN Congenital melanocytic nevi: update in genetics and management Curr Opin Pediatr 2016 28 4 476 82 10.1097/MOP.0000000000000384Open DOISearch in Google Scholar

Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133(9):2229-36. doi: 10.1038/jid.2013.70. Kinsler VA Thomas AC Ishida M Bulstrode NW Loughlin S Hing S et al Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS J Invest Dermatol 2013 133 9 2229 36 10.1038/jid.2013.70367897723392294Open DOISearch in Google Scholar

Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441-51. doi: 10.1016/j.jaad.2012.05.043. Krengel S Scope A Dusza SW Vonthein R Marghoob AA New recommendations for the categorization of cutaneous features of congenital melanocytic nevi J Am Acad Dermatol 2013 68 3 441 51 10.1016/j.jaad.2012.05.04322982004Open DOISearch in Google Scholar

Polubothu S, McGuire N, Al-Olabi L, Baird W, Bulstrode N, Chalker J, et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br J Dermatol. 2020;182(2):434-43. doi: 10.1111/bjd.18106. Polubothu S McGuire N Al-Olabi L Baird W Bulstrode N Chalker J et al Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi Br J Dermatol 2020 182 2 434 43 10.1111/bjd.18106702814031111470Open DOISearch in Google Scholar

Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, et al. Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol. 2009;129(1):139-47. doi: 10.1038/jid.2008.203. Dessars B De Raeve LE Morandini R Lefort A El Housni H Ghanem GE et al Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis J Invest Dermatol 2009 129 1 139 47 10.1038/jid.2008.20318633438Open DOISearch in Google Scholar

Bekiesińska-Figatowska M, Szczygielski O, Boczar M, Mądzik J, Klepacka T, Michalak E, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging. 2014;38(2):79-84. doi: 10.1016/j.clinimag.2013.10.001. Bekiesińska-Figatowska M Szczygielski O Boczar M Mądzik J Klepacka T Michalak E et al Neurocutaneous melanosis in children with giant congenital melanocytic nevi Clin Imaging 2014 38 2 79 84 10.1016/j.clinimag.2013.10.00124239041Open DOISearch in Google Scholar

Sawicka E, Szczygielski O, Żak K, Pęczkowski P, Michalak E, Bekiesińska-Figatowska M. Giant congenital melanocytic nevi: selected aspects of diagnostics and treatment. Med Sci Monit. 2015 Jan 11;21:123-32. doi: 10.12659/MSM.891279. Sawicka E Szczygielski O K Żak P Pęczkowski E Michalak M Bekiesińska-Figatowska Giant congenital melanocytic nevi: selected aspects of diagnostics and treatment Med Sci Monit 2015 Jan 11 21123 32 10.12659/MSM.891279429899825577155Open DOISearch in Google Scholar

Roh MR, Eliades P, Gupta S, Tsao H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 2015;28(6):661-72. doi: 10.1111/pcmr.12412. Roh MR Eliades P Gupta S Tsao H Genetics of melanocytic nevi Pigment Cell Melanoma Res 2015 28 6 661 72 10.1111/pcmr.12412460961326300491Open DOISearch in Google Scholar

Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126(9):2111-8. doi: 10.1038/sj.jid.5700366. Ichii-Nakato N Takata M Takayanagi S Takashima S Lin J Murata H et al High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi J Invest Dermatol 2006 126 9 2111 8 10.1038/sj.jid.570036616691193Open DOISearch in Google Scholar

Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134(4):1067-74. doi: 10.1038/jid.2013.429. Charbel C Fontaine RH Malouf GG Picard A Kadlub N El-Murr N et al NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi J Invest Dermatol 2014 134 4 1067 74 10.1038/jid.2013.42924129063Open DOISearch in Google Scholar

Stark MS. Large-giant congenital melanocytic nevi: moving beyond NRAS mutations. J Invest Dermatol. 2019;139(4):756-9. doi: 10.1016/j.jid.2018.10.003. Stark MS Large-giant congenital melanocytic nevi: moving beyond NRAS mutations J Invest Dermatol 2019 139 4 756 9 10.1016/j.jid.2018.10.00330904080Open DOISearch in Google Scholar

Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020;10(4):1103-14. Alqathama A BRAF in malignant melanoma progression and metastasis: potentials and challenges Am J Cancer Res 2020 10 4 1103 14Search in Google Scholar

Frech M, Darden TA, Pedersen LG, Foley CK, Charifson PS, Anderson MW, Wittinghofer A. Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical study. Biochemistry. 1994;33(11):3237-44. doi: 10.1021/bi00177a014. Frech M Darden TA Pedersen LG Foley CK Charifson PS Anderson MW Wittinghofer A Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical study Biochemistry 1994 33 11 3237 44 10.1021/bi00177a0148136358Open DOISearch in Google Scholar

Hélias-Rodzewicz Z, Funck-Brentano E, Terrones N, Beauchet A, Zimmermann U, Marin C, et al. Variation of mutant allele frequency in NRAS Q61 mutated melanomas. BMC Dermatol. 2017;17(1):9. doi: 10.1186/s12895-017-0061-x. Hélias-Rodzewicz Z Funck-Brentano E Terrones N Beauchet A Zimmermann U Marin C et al Variation of mutant allele frequency in NRAS Q61 mutated melanomas BMC Dermatol 2017 17 1 9 10.1186/s12895-017-0061-x549412828668077Open DOISearch in Google Scholar

Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbour NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179-82. doi: 10.1038/sj.jid.5700490. Bauer J Curtin JA Pinkel D Bastian BC Congenital melanocytic nevi frequently harbour NRAS mutations but no BRAF mutations J Invest Dermatol 2007 127 1 179 82 10.1038/sj.jid.570049016888631Open DOISearch in Google Scholar

Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, et al. Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations. J Invest Dermatol. 2019;139(4):900-8. doi: 10.1016/j.jid. 2018.07.045. Martins da Silva V Martinez-Barrios E Tell-Martí G Dabad M Carrera C Aguilera P et al Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations J Invest Dermatol 2019 139 4 900 8 10.1016/j.jid.2018.07.04530359577Open DOISearch in Google Scholar

Pedersen M, Küsters-Vandevelde HVN, Viros A, Groenen PJTA, Sanchez-Laorden B, Gilhuis JH, et al. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov. 2013 ;3(4) :458-69. doi : 10.1158/2159-8290.CD-12-0464. Pedersen M Küsters-Vandevelde HVN Viros A Groenen PJTA Sanchez-Laorden B Gilhuis JH et al Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes Cancer Discov 2013 3 4 458 69 10.1158/2159-8290.CD-12-0464399938223303902Open DOISearch in Google Scholar

Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014;4(12):1418-29. doi: 10.1158/2159-8290.CD-14-0729. Burd CE Liu W Huynh MV Waqas MA Gillahan JE Clark KS et al Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma Cancer Discov 2014 4 12 1418 29 10.1158/2159-8290.CD-14-0729425818525252692Open DOISearch in Google Scholar

AACR Project GENIE Consortium. AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31. doi: 10.1158/2159-8290.CD-17-0151. AACR Project GENIE Consortium AACR Project GENIE: Powering Precision Medicine through an International Consortium Cancer Discov 2017 7 8 818 31 10.1158/2159-8290.CD-17-0151561179028572459Open DOISearch in Google Scholar

eISSN:
2719-535X
Lingua:
Inglese
Frequenza di pubblicazione:
Volume Open
Argomenti della rivista:
Medicine, Clinical Medicine, Pediatrics and Juvenile Medicine, Paediatric Haematology and Oncology, Public Health